So far Gerald has shown to have the anti-midas touch going into any important event. I also see the P2 trial for ELTO now has been pushed back to Q1 15 instead of Q4 14. Yeah, I know they have listed both but I think it is safe to say it's not happening this year based on the other missed time lines from Gerald. I am still hoping to hear on the 22n that Gerald is going to be taking on a new role at Amarantus while they bring in someone who actually has experience in growing a biotech.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.